Comparison of the risks of cytologic surveillance of women with atypical cells or low-grade abnormalities on cervical smear: Review of the literature

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 76, Issue 2, 1998, Pages 193-199

  Baldauf, Jean Jacques ^a   Ritter, Jean ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Atypical squamous cells of undetermined signifinance; Cervival smears; Low grade squmous intraepithelial lesions

Indexed keywords

CANCER DIAGNOSIS; COLPOSCOPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 0032007522     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(97)00171-1     Document Type: Article

References (40)

1. Kurman R.J., Henson D.E., Herbst A.L., Noller K.L., Schiffman M.H. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. J Am Med Assoc. 271:1994;1866-1869.
2. Sedlacek T.V. Clinical option in dealing with minor cytologic abnormalities. Colposcopist. 14:1992;1-2.
3. Raffle A.E., Alden B., Mackenzie E.F. Detection rates for abnormal cervical smears: what are we screening for? Lancet. 345:1995;1469-1473.
4. Duncan ID. Guidelines for clinical practise and programme management - NHS Cervical Screening Programme. National Coordinating Network, Oxford Regional Health Authority, 1992.
5. Baldauf JJ, Dreyfus M, Ritter J, Meyer P, Philippe E. Comparison of the screening histories of incident cases of cervical cancer and high grade CIN. Acta Cytol 1997; in press.
6. Janerich D.T., Hadjimichael O., Schwartz P.E., Lowell D.M., Meigs J.W., Merino M.J., Flanery J.T., Podenak A.P. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 85:1995;791-794.
7. Nielsen N.H., Jensen H. Screening for cancer of the uterine cervix in Greenland. APMIS. 101:1993;290-294.
8. Marcus A.C., Crane L.A., Kaplan C.P., Reading A.E., Savage E., Gunning J., Bernstein G., Berek J.S. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care. 30:1992;216-230.
9. Kurman RJ, Solomon D. The Bethesda System for reporting cervical-vaginal cytologic diagnoses, New York: Springer-Verlag, 1993:30-47.
10. Taylor R.R., Guerrieri J.P., Nash J.D., Henry M.R., O'Connor D.M. Atypical cervical cytology. Colposcopic follow-up using the Bethesda System. J Reprod Med. 38:1993;443-447.
11. Slawson D.C., Bennett J.H., Simon L.J., Herman J.M. Should all women with cervical atypia be referred for colposcopy: a HARNET study. J Fam Pract. 38:1994;387-392.
12. Ridgley R., Hernandez E., Cruz C., Miyazawa K. Abnormal Papanicolaou smears after earlier smears with atypical squamous cells. J Reprod Med. 33:1988;285-288.
13. Himmelstein L.R. Evaluation of inflammatory atypia. A literature review. J Reprod Med. 34:1989;634-637.
14. Shafi M.I. Management of women with mild dyskaryosis. Cytological surveillance avoids overtreatment. Br Med J. 309:1994;590-591.
15. Widra E.A., Dookhan D., Jordan A., McCue P., Bibbo M., Dunton C.J. Evaluation of the atypical cytologic smear. Validity of the 1991 Bethesda System. J Reprod Med. 39:1994;682-684.
16. Pearlstone A.C., Grigsby P.W., Mutch D.G. High rates of atypical cervical cytology: occurrence and clinical significance. Obstet Gynecol. 80:1992;191-195.
17. DiBonito L., Falconieri G., Tomasic G., Colautti I., Bonifacio D., Dudine S. Cervical cytopathology. An evaluation of its accuracy based on cytohistologic comparison. Cancer. 72:1993;3002-3006.
18. Wright T.C., Sun X.W., Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol. 85:1995;202-210.
19. Mayeaux E.J., Harper M.B., Abreo F., Pope J.B., Philips G.S. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cytology. J Fam Pract. 40:1995;57-62.
20. Shafi M.I., Luesley D.M. Management of low grade lesions: follow-up or treat? Bail Clin Obstet Gynaecol. 9:1995;121-131.
21. Lonky N.M., Navarre G.L., Saunders S., Sadeghi M., Wolde-Tsadik G. Low-grade Papanicolaou smears and the Bethesda system: a prospective cytohistopathologic analysis. Obstet Gynecol. 85:1995;716-720.
22. Jones M.H., Jenkins D., Cuzick J., Wolfendale M.R., Jones J.J., Balogun-Lynch C., Usherwood M.M., Singer A. Mild cervical dyskaryosis: safety of cytological surveillance. Lancet. 339:1992;1440-1443.
23. Anderson D.J., Flannelly G.M., Kitchener H.C., Fisher P.M., Mann E.M., Campbell M.K., Templeton A. Mild and moderate dyskaryosis: can women be selected for colposcopy on the basis of social criteria? Br Med J. 305:1992;84-87.
24. Regi A., Krishnaswami H., Jairaj P., Seshadri L. Management of patients with mildly dysplastic cervical smears. J Reprod Med. 39:1994;455-458.
25. Kirkegaard O., Byrjalsen C., Frandsen K.H., Hansen K.C., Frydenberg M. Diagnostic accuracy of cytology and colposcopy in cervical squamous intraepithelial lesions. Acta Obstet Gynecol Scand. 73:1994;648-651.
26. Hall S., Wu T.C., Soudi N., Sherman M.E. Low-grade squamous intraepithelial lesions: cytologic predictors of biopsy confirmation. Diag Cytopathol. 10:1994;3-9.
27. Parazzini F., Sideri M., Restelli S., Schettino F., Chatenoud L., Crosignani P.G. Determinants of high-grade dysplasia among women with mild dyskaryosis on cervical smear. Obstet Gynecol. 86:1995;754-757.
28. Roland P.Y., Naumann R.W., Alvarez R.D., Kilgore L.C., Partridge E.E. A decision analysis of practice patterns used in evaluating and treating abnormal Pap smears. Gynecol Oncol. 59:1995;75-80.
29. Jones B.A., Novis D.A. Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories. Arch Pathol Lab Med. 120:1996;523-531.
30. Montz F.J., Monk B.J., Fowler J.M., Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol. 80:1992;385-388.
31. Robertson J.H., Woodend B.E., Crozier E.H., Hutchinson J. Risk of cervical cancer associated with mild dyskaryosis. Br Med J. 297:1988;18-21.
32. Fletcher A., Metaxas N., Grubb C., Chamberlain J. Four and a half year follow up of women with dyskaryotic cervical smears. Br Med J. 301:1990;641-644.
33. Giles J.A., Deery A., Crow J., Walker P. The accuracy of repeat cytology in women with mildly dyskaryotic smears. Br J Obstet Gynaecol. 96:1989;1067-1070.
34. Flannelly G., Anderson D., Kitchener H.C., Mann E.M., Campbell M., Fisher P., Walker F., Templeton A.A. Management of women with mild and moderate cervical dyskaryosis. Br Med J. 308:1994;1399-1403.
35. Nasiell K., Roger V., Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol. 67:1986;665-669.
36. Cooper P., Kirby A.J., Spiegelhalter D.J., Whitehead A.L., Patterson A. Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy. Cytopathol. 3:1992;331-339.
37. Herbert A., Gregory M., Wagstaff H.F. Follow up of women with a history of mildly abnormal cervical smears which have returned to normal without treatment. Cytopathol. 5:1994;177-183.
38. Kirby A.J., Spiegelhalter D.J., Day N.E., Fenton L., Swanson K., Mann E.M., Macgregor J.E. Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet. 339:1992;828-831.
39. Sherlaw-Johnson C., Gallivan S., Jenkins D., Jones M.H. Cytological screening and management of abnormalities in prevention of cervical cancer: an overview with stochastic modelling. J Clin Pathol. 47:1994;430-435.
40. Johnson N., Sutton J., Thornton J.G., Lilford R.J., Johnson V.A., Peel K.R. Decision analysis for best management of mildly dyskaryotic smear. Lancet. 342:1993;91-96.